# Lawrence Leeman, M.D., M.P.H. – FDA Inspection, Aug 28, 2026

Source: https://www.keypedia.com/records/fda_inspections/lawrence-leeman-md-mph/8fccce1c-8e65-43c9-b0f7-6280d9dd3f8c
Source feed: FDA_Inspections

> FDA inspection 1333360 of Lawrence Leeman, M.D., M.P.H., August 28, 2026. 2 citations under 21 CFR part 312. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1333360
- Company Name: Lawrence Leeman, M.D., M.P.H.
- Inspection Date: 2026-08-28
- Project Area: Bioresearch Monitoring
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Denver District Office
- Citation Count: 2

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/audrey-j-yarbrough/1bab3d1a-3246-451e-96fb-4ce52185e850)

Company: https://www.keypedia.com/companies/lawrence-leeman-md-mph/4786d1df-aeef-455f-99b5-0d1dc3f7fb62

Office: https://www.keypedia.com/offices/denver-district-office/93b79063-390c-4759-af6c-5da7e388face